• InterView
• "New targeted therapies for bile duct cancer are in need"
• by Son, Hyung-Min Sep 6, 2024 05:48am

• InterView
• AstraZeneca seeks mutual growth through open collaboration
• by Hwang, Byung-woo Aug 27, 2024 05:50am

• InterView
• ‘We need to actively use acetaminophen ER tablets'
• by Eo, Yun-Ho Jul 18, 2024 05:49am

• InterView
• ‘Ireland, a bridgehead for companies entering the EU mkt'
• by Nho, Byung Chul Jul 10, 2024 05:48am

• InterView
• “Prolia demonstrated a long-term treatment effect"
• by Son, Hyung-Min Jul 5, 2024 05:49am

• InterView
• ‘Leqembi enables prevention of Alzheimer's disease’
• by Son, Hyung-Min Jun 27, 2024 05:47am

• InterView
• 1 year after Lynparza approved for early-stage breast cancer
• by Son, Hyung-Min May 7, 2024 05:50am

• InterView
• 'BMS will invest in and improve access to new drugs in KOR'
• by Eo, Yun-Ho Apr 15, 2024 06:06am

• InterView
• ‘New head, new drugs…Bayer’s transition has just begun'
• by Eo, Yun-Ho Mar 25, 2024 05:59am

• InterView
• “Solid position of JAK inhibitors despite ongoing concerns"
• by Eo, Yun-Ho Mar 15, 2024 05:48am